As of April 2025 KOBAYASHI Pharmaceutical has a market cap of NZ$4.87 Billion. This makes KOBAYASHI Pharmaceutical the world's 3530th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$4.87 B | -7.81% |
2024 | NZ$5.29 B | -6.34% |
2023 | NZ$5.64 B | -30.11% |
2022 | NZ$8.08 B | -9.59% |
2021 | NZ$8.94 B | -32.5% |
2020 | NZ$13.24 B | 34.05% |
2019 | NZ$9.88 B | 23.81% |
2018 | NZ$7.98 B | 10.79% |
2017 | NZ$7.20 B | 40.33% |
2016 | NZ$5.13 B | 4.15% |
2015 | NZ$4.92 B | 60.04% |
2014 | NZ$3.07 B | 10.49% |
2013 | NZ$2.78 B | 17.41% |
2012 | NZ$2.37 B | -13.23% |
2011 | NZ$2.73 B | 11.42% |
2010 | NZ$2.45 B | 8.8% |
2009 | NZ$2.25 B | -27.28% |
2008 | NZ$3.10 B | 49.35% |
2007 | NZ$2.07 B | -4.97% |
2006 | NZ$2.18 B |
On Apr 5th, 2025 the market cap of KOBAYASHI Pharmaceutical was reported to be: